Latest filing published 09 Mar 2026 for NU Skin Enterprises, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
James D. Thomas (senior executive) discloses dealings in NU Skin Enterprises, Inc. to SEC (Form 4). The record holds 22 filings, for trades running from 15 February 2020 to 6 March 2026.
Every open-market trade on record is a sale: 1 sale worth €63k. Outside the open market, there are 20 share grants and 1 option exercise.
The latest filing, published on 9 March 2026, reports a share grant in NU Skin Enterprises, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations